Jason McCarthy Analyst PerformanceSenior Managing Director, Head of Biotechnology Research at Maxim GroupJason McCarthy is a stock analyst at Maxim Group focused in the healthcare sector, covering 114 publicly traded companies. Over the past year, Jason McCarthy has issued 39 stock ratings, including buy and hold recommendations. While full access to Jason McCarthy's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jason McCarthy's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings680 Last 11 YearsBuy Recommendations89.54% 599 Buy RatingsCompanies Covered114 Unique Companies Ratings Distribution669RatingsDistribution of strong buy, buy, hold, and sell ratings by Jason McCarthy.RatingPercentageCount Strong Buy0.0%0 ratings Buy89.5%599 ratings Hold10.5%70 ratings Sell0.0%0 ratingsOut of 669 total stock ratings issued by Jason McCarthy at Maxim Group, the majority (89.5%) have been Buy recommendations, followed by 10.5% Hold.Best & Worst CallsBest Call0000000.0%SLSNov 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CEROMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ78.1% of companies on NASDAQ89 companiesNYSEAMERICAN9.6% of companies on NYSEAMERICAN11 companiesOTCMKTS7.0% of companies on OTCMKTS8 companiesNYSE4.4% of companies on NYSE5 companiesTSE0.9% of companies on TSE1 companyJason McCarthy, an analyst at Maxim Group, currently covers 114 companies listed on NASDAQ, NYSEAMERICAN, OTCMKTS, NYSE and TSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare110 companies96.5%Finance2 companies1.8%Technology2 companies1.8%Jason McCarthy of Maxim Group specializes in stock coverage within the Healthcare sector, with additional focus on Finance and Technology companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY65 companies57.0%PHARMACEUTICALS39 companies34.2%LIFE SCIENCES TOOLS & SERVICES2 companies1.8%SOFTWARE2 companies1.8%HEALTHCARE EQUIPMENT & SUPPLIES2 companies1.8%BANKS1 company0.9%CAPITAL MARKETS1 company0.9%HEALTHCARE PROVIDERS & SERVICES1 company0.9%MEDICAL LABORATORIES1 company0.9% About Jason McCarthyJason McCarthy, Ph.D. is a Senior Managing Director and Head of Biotechnology Research at Maxim Group. Dr. McCarthy joined Maxim Group in July 2014. Prior to joining Maxim he received his doctoral degree in Biomedical Sciences at the Albert Einstein College of Medicine. Dr. McCarthy also holds a Master’s degree in both Biomedical Research (Albert Einstein College of Medicine) and Molecular Biology (Adelphi University), as well as a B.S. in Biochemistry from Stony Brook University. Jason McCarthy's Ratings History at Maxim Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAKTXAkari Therapeutics7/20/2026Upgrade$11.01$30.00Buy$0.0000.00% ROIRNTXRein Therapeutics7/20/2026Initiated Coverage$0.86$4.00Buy$0.0000.00% ROIIMMPPrima BioMed6/17/2026Upgrade$0.37Buy$0.0000.00% ROICNTXContext Therapeutics6/16/2026Lower Price Target$0.68$4.00Buy$0.0000.00% ROIZVRAZevra Therapeutics6/10/2026Boost Price Target$13.67$35.00Buy$0.0000.00% ROIRZLTRezolute6/2/2026Boost Price Target$4.00$14.00Buy$0.0000.00% ROIFLNACassava Sciences5/26/2026Reiterated Rating$1.41$5.00Buy$0.0000.00% ROINTHINeonc Technologies5/18/2026Initiated Coverage$5.50$20.00Buy$0.0000.00% ROICMPSCompass Pathways5/15/2026Boost Price Target$10.18$20.00Buy$0.0000.00% ROIRZLTRezolute5/14/2026Boost Price Target$3.49$10.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. IMNNImunon4/17/2026Set Price Target$3.09$10.00Buy$0.0000.00% ROIIMNNImunon4/17/2026Initiated Coverage$3.13Buy$0.0000.00% ROIAKTXAkari Therapeutics4/8/2026Downgrade$3.80Hold$0.0000.00% ROIRVPHReviva Pharmaceuticals4/8/2026Downgrade$0.82Hold$0.0000.00% ROITOVXTheriva Biologics3/31/2026Upgrade$0.20$1.00Buy$0.0000.00% ROIMNOVMediciNova3/23/2026Reiterated Rating$1.56$6.00Buy$0.0000.00% ROISLSSELLAS Life Sciences Group3/12/2026Boost Price Target$5.37$10.00Buy$0.0000.00% ROICLRBCellectar Biosciences3/10/2026Upgrade$2.75Buy$0.0000.00% ROIPLYXPolaryx Therapeutics2/27/2026Initiated Coverage$3.19$10.00Buy$0.0000.00% ROICODXCo-Diagnostics1/23/2026Downgrade$2.92Hold$0.0000.00% ROIVTGNVistaGen Therapeutics12/17/2025Reiterated Rating$0.86Hold$0.0000.00% ROIRZLTRezolute12/12/2025Set Price Target$1.60$4.00$0.0000.00% ROICAPRCapricor Therapeutics12/4/2025Boost Price Target$23.17$50.00Buy$0.0000.00% ROICODXCo-Diagnostics11/26/2025Upgrade$0.36Hold$0.0000.00% ROICODXCo-Diagnostics11/26/2025Initiated Coverage$9.75$45.00Buy$0.0000.00% ROIARTLArtelo Biosciences11/19/2025Reiterated Rating$1.84Hold$0.0000.00% ROICEROCERo Therapeutics11/3/2025Downgrade$0.13Hold$0.0000.00% ROIABPAbpro10/21/2025Downgrade$0.20Hold$0.0000.00% ROIGANXGain Therapeutics10/7/2025Boost Price Target$2.02$7.00Buy$0.0000.00% ROIHINDVyome10/2/2025Reiterated Rating$5.50$15.00Buy$0.0000.00% ROIHINDVyome10/2/2025Reiterated Rating$5.36$15.00Buy$0.0000.00% ROIADILAdial Pharmaceuticals9/30/2025Upgrade$8.31$37.50Buy$0.0000.00% ROIAZTRAzitra9/24/2025Lower Price Target$0.73$4.00Buy$0.0000.00% ROIRZLTRezolute9/18/2025Boost Price Target$8.33$20.00Buy$0.0000.00% ROICNSPCNS Pharmaceuticals9/12/2025Upgrade$7.74$20.00Buy$0.0000.00% ROINEUPNeuphoria Therapeutics9/11/2025Boost Price Target$14.06$35.00Buy$0.0000.00% ROICHRSCoherus Oncology9/4/2025Upgrade$1.26$4.00Buy$0.0000.00% ROIPSTVPlus Therapeutics8/18/2025Lower Price Target$13.78$75.00Buy$0.0000.00% ROIRVPHReviva Pharmaceuticals8/15/2025Lower Price Target$10.80$40.00Buy$0.0000.00% ROIBCLIBrainstorm Cell Therapeutics7/23/2025Downgrade$0.71Hold$0.0000.00% ROIHere’s the stock symbol I’ve promised (Ad)Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.Get the stock name and ticker symbol free of charge todayAKTXAkari Therapeutics7/18/2025Initiated Coverage$45.20$200.00Buy$00.0000.00% ROISLSSELLAS Life Sciences Group7/16/2025Boost Price Target$1.87$7.00Buy$00.0000.00% ROIINMBINmune Bio7/2/2025Lower Price Target$2.34$8.00Buy$0.0000.00% ROICTXRCitius Pharmaceuticals5/23/2025Downgrade$0.72Hold$0.0000.00% ROIMTVAMetaVia5/19/2025Lower Price Target$7.48$33.00Buy$0.0000.00% ROICEROCERo Therapeutics5/19/2025Initiated Coverage$11.80$60.00Buy$0.0000.00% ROICLRBCellectar Biosciences5/14/2025Reiterated Rating$0.24Hold$0.0000.00% ROIFRSTPrimis Financial5/12/2025Initiated Coverage$8.96$1.00Buy$00.0000.00% ROIPMNPromis Neurosciences5/12/2025Initiated Coverage$12.41$75.00Buy$00.0000.00% ROITOVXTheriva Biologics5/8/2025Reiterated Rating$0.81Hold$0.0000.00% ROIMDCXMedicus Pharma5/8/2025Boost Price Target$4.34$20.00Buy$0.0000.00% ROIKAPAKairos Pharma3/27/2025Initiated Coverage$0.93$4.00Buy$0.0000.00% ROIMBRXMoleculin Biotech3/25/2025Upgrade$26.50$100.00Buy$0.0000.00% ROICNSPCNS Pharmaceuticals3/25/2025Reiterated Rating$1.45Hold$0.0000.00% ROIANIXAnixa Biosciences3/21/2025Initiated Coverage$3.15$10.00Buy$0.0000.00% ROIONCYOncolytics Biotech3/10/2025Lower Price Target$0.65$3.00Buy$0.0000.00% ROIABPAbpro2/24/2025Initiated Coverage$23.75$120.00Buy$0.0000.00% ROIINMBINmune Bio2/13/2025Boost Price Target$9.30$30.00Buy$0.0000.00% ROIMBRXMoleculin Biotech2/12/2025Downgrade$0.51Hold$0.0000.00% ROIKZIANovogen2/6/2025Initiated Coverage$7.00$15.00Buy$0.0000.00% ROIATHEAlterity Therapeutics1/30/2025Boost Price Target$4.57$12.00Buy$0.0000.00% ROIOSTXOS Therapies1/16/2025Boost Price Target$4.31$15.00Buy$0.0000.00% ROIRVPHReviva Pharmaceuticals1/10/2025Upgrade$40.62$140.00Buy$0.0000.00% ROIMDCXMedicus Pharma12/17/2024Initiated Coverage$2.95$10.00Buy$0.0000.00% ROIATHEAlterity Therapeutics12/12/2024Initiated Coverage$2.27$8.00Buy$0.0000.00% ROIOSTXOS Therapies11/26/2024Initiated Coverage$2.02$8.00Buy$0.0000.00% ROIQNCXQuince Therapeutics11/7/2024Initiated Coverage$292.00$1,200.00Buy$000.0000.00% ROIMTNBMatinas Biopharma10/31/2024Reiterated Rating$0.62Hold$0.0000.00% ROIANVSAnnovis Bio10/25/2024Upgrade$9.07$25.00Buy$0.0000.00% ROICNSPCNS Pharmaceuticals9/10/2024Upgrade$85.20$300.00Buy$0.0000.00% ROIRVPHReviva Pharmaceuticals8/16/2024Reiterated Rating$0.69Hold$0.0000.00% ROIDAREDare Bioscience8/14/2024Reiterated Rating$3.60Hold$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenBarclaysRoyal Bank Of CanadaMorgan StanleyJefferies Financial GroupThe Goldman Sachs GroupBMO Capital MarketsSanford C. BernsteinBerenberg BankBNP Paribas ExaneCompass PointPiper SandlerCanadian Imperial Bank of CommerceWeiss RatingsUBS Group Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
